Interaction between metamizol and tramadol in a model of acute visceral pain in rats

European Journal of Pain

Volumn 7, Issue 5, 2003, Pages 439-448

  Poveda, Raquel ^a   Planas, Eulalia ^a   Pol, Olga ^b   Romero, Asunción ^a   Sánchez, Silvia ^a   Puig, Margarita M ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Antagonism; Antinociception; Interactions; Isobolograms; Metamizol; Opioids; Synergy; Tramadol

Indexed keywords

ANTIPYRETIC ANALGESIC AGENT; DIPYRONE; ETACRYNIC ACID; MU OPIATE RECEPTOR AGONIST; NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OPIATE; TRAMADOL;

ANALGESIA; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; WRITHING TEST;

EID: 0041821578     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(03)00003-X     Document Type: Article

References (30)

1. Abbate R, Gori AM, Pinto S, Attanasio M, Paniccia R, Coppo M, Castellani S, Guisti B, Boddi M, Neri Serneri SGG. Cyclooxygenase and lipooxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone. Prostaglandins Leukot Essent Fatty Acids 1990;41:89-93.
2. Aguirre-Bañuelos P, Granados-Soto V. Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone. J Pharmacol Toxicol Methods 1999;42:79-85.
3. Begon S, Pickering G, Eschalier A, Dubray C. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology 2002;96:627-32.
4. Berenbaum MC. What is synergy?. Pharmacol Exp Ther 1989;41:931-35.
5. Campos C, de Gregorio R, García-Nieto R, Gago F, Ortíz P, Alemany S. Regulation of ciclooxygenase activity by metamizol. Eur J Pharmacol 1999;378:339-47.
6. Carlsson KH, Helmreich J, Jurna I. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone). Pain 1986;27:373-90.
7. Caudle RM, Williams GM. The misuse of analysis of variance to detect synergy in combination drug studies. Pain 1993;55:313-7.
8. Dayer P, Desmeules J, Collar L. Pharmacology of Tramadol. Drugs 1997;53(Suppl. 2):18-24.
9. Duarte ID, Santos IR, Lorenzetti BB, Ferreira SH. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol 1992;217:225-7.
10. Garibaldi JA, Elder MF. Evaluation of ketorolac (Toradol) with varying amounts of codeine for postoperative pain control. Int J Oral Maxillofac Surg 2002;31:276-80.
11. Hernández N, Vanegas H. Antinocieption induced by PAG-microinjected dipyrone (metamizol) in rats: involvement of spinal engogenous opioids. Brain Res 2001;896:175-8.
12. Herrero JF, Headley PM. Reversal by naloxone of the spinal antinociceptive actions of asystemically-administered NSAID. Br J Pharmacol 1996;118:968-72.
13. Jaques R. Antagonism of non-steroidal anti-inflammatory drugs and narcotic analgesics against ethacrinic acid induced writhing. Arzneimmitel-forschung/Drug Res 1977;27:1698-700.
14. Lee YW, Yaksh TL. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology 1995;82:741-8.
15. Lehman KA. New developments in patient-controlled postoperative analgesia. Ann Med 1995;27:757-67.
16. Levy M, Zylber-katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 1995;28:216-34.
17. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc 2002;133:861-71.
18. Miaskoski C, Sutters KA, Taiwo YO, Levine JD. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioids agonists. Pain 1992;49:137-44.
19. Montes A, Warner W, Puig MM. Use of intravenous patient controlled analgesia for the documentation of synergy between tramadol and metamizol. Br J Anesth 2000;85:217-23.
20. Puig MM, Warner W, Pol O. Intestinal inflammation and morphine tolerance, alter the interaction between morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 2000;93:219-30.
21. Raffa RB, Friderichs E, Reimann W. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, and "atypical" opioid analgesic. J Pharmacol Exp Ther 1992;160:275-85.
22. Shimada SG, Otterness IG, Stitt JT. A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 1994;41:142-88.
23. Tallarida RJ, Stone DJ, Mc Cary JD, Raffa RB. Response surface analysis of synergism between morphine and clonidine. J Pharmacol Exp Ther 1999;289:8-13.
24. Tallarida RJ, Stone DJ, Raffa RB. Efficient designs for studying synergistic drug combinations. Pharmacology Letters Life Sciences 1997;61:417-21.
25. Tallarida RJ. Pharmatools Pro. Pharmacologycal Analysis Research Software. Boca Raton, Florida: Chapman & Hall/CRC; 2001a.
26. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001b;298:865-72.
27. Tallarida RJ. Statistical analysis of drug combinations for synergism. Pain 1992;49:93-7.
28. Taylor J, Mellström B, Fernaud I, Naranjo JR. Metamizol potentiates morphine effects on visceral pain and evoked c-Fos inmunoreactivity in spinal cord. Eur J Pharmacol 1998;351:39-47.
29. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrococeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001;91:23-31.
30. Vanegas H, Tortorici V, Eblen-Zsjjur A, Vasquez E. PAG-microinjected dipyrone (metamizol) inhibits responses of spinal dorsal horn neurons to natural noxious stimulation in rats. Brain Res 1997;6:171-4.